Surgical Oncology
Volume 19, Issue 1 , Pages 33-37 , March 2010

Endometriosis related to family history of malignancies in the Yale series

  • Ioannis M. Matalliotakis

      Affiliations

    • Division of Reproductive Endocrinology and Infertility, Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, CT, USA
    • Department of Obstetrics and Gynecology, University of Crete, Heraklion, Greece
    • Corresponding Author InformationCorresponding author. Department of Obstetrics and Gynecology, University of Crete, PO Box 1352, Heraklion, Crete, Greece.
    • ,
  • Hakan Cakmak

      Affiliations

    • Division of Reproductive Endocrinology and Infertility, Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, CT, USA
    • ,
  • Georgios D. Krasonikolakis

      Affiliations

    • Department of Obstetrics and Gynecology, University of Crete, Heraklion, Greece
    • ,
  • Despina Dermitzaki

      Affiliations

    • Department of Obstetrics and Gynecology, University of Crete, Heraklion, Greece
    • ,
  • Yvoni Fragouli

      Affiliations

    • Department of Hygiene and Epidemiology, University of Athens, Athens, Greece
    • ,
  • Georges Vlastos

      Affiliations

    • Department of Obstetrics and Gynecology, Division of Gynecology, Senology Unit, Geneva University Hospitals, Geneva, Switzerland
    • ,
  • Aydin Arici

      Affiliations

    • Division of Reproductive Endocrinology and Infertility, Department of Obstetrics, Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, CT, USA

,Accepted 14 February 2009.

References 

  1. Lapp T. ACOG issues recommendations for the management of endometriosis. American College of Obstetricians and Gynecologists. Am Fam Physician. 2000;62:1431, 1434
  2. Gucer F, Pieber D, Arikan MG. Malignancy arising in extraovarian endometriosis during estrogen stimulation. Eur J Gynaecol Oncol. 1998;19:39–41
  3. Heaps JM, Nieberg RK, Berek JS. Malignant neoplasms arising in endometriosis. Obstet Gynecol. 1990;75:1023–1028
  4. Modesitt SC, Tortolero-Luna G, Robinson JB, Gershenson DM, Wolf JK. Ovarian and extraovarian endometriosis-associated cancer. Obstet Gynecol. 2002;100:788–795
  5. Leiserowitz GS, Gumbs JL, Oi R, Dalrymple JL, Smith LH, Ryu J, et al. Endometriosis-related malignancies. Int J Gynecol Cancer. 2003;13:466–471
  6. Brooks JJ, Wheeler JE. Malignancy arising in extragonadal endometriosis: a case report and summary of the world literature. Cancer. 1977;40:3065–3073
  7. Melin A, Sparen P, Persson I, Bergqvist A. Endometriosis and the risk of cancer with special emphasis on ovarian cancer. Hum Reprod. 2006;21:1237–1242
  8. Newman LA, Kuerer HM, Hunt KK, Vlastos G, Ames FC, Ross MI, et al. Collective review: prophylactic mastectomy. J Am Coll Surg. 2000;191(3):322–330
  9. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst. 1994;86:1600–1608
  10. Revised American Fertility Society classification of endometriosis: 1985. Fertil Steril. 1985;43:351–352
  11. Reimnitz C, Brand E, Nieberg RK, Hacker NF. Malignancy arising in endometriosis associated with unopposed estrogen replacement. Obstet Gynecol. 1988;71:444–447
  12. Martin DC. Cancer and endometriosis: do we need to be concerned?. Semin Reprod Endocrinol. 1997;15:319–324
  13. Zanetta GM, Webb MJ, Li H, Keeney GL. Hyperestrogenism: a relevant risk factor for the development of cancer from endometriosis. Gynecol Oncol. 2000;79:18–22
  14. Frank TS, Critchfield GC. Inherited risk of women's cancers: what's changed for the practicing physician?. Clin Obstet Gynecol. 2002;45:671–683[discussion 730–2]
  15. Varma V, Cohen C. Immunohistochemical and molecular markers in the diagnosis of hepatocellular carcinoma. Adv Anat Pathol. 2004;11:239–249
  16. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57–70
  17. Arvanitis DA, Koumantakis GE, Goumenou AG, Matalliotakis IM, Koumantakis EE, Spandidos DA. CYP1A1, CYP19, and GSTM1 polymorphisms increase the risk of endometriosis. Fertil Steril. 2003;79(Suppl. 1):702–709
  18. Goumenou AG, Arvanitis DA, Matalliotakis IM, Koumantakis EE, Spandidos DA. Microsatellite DNA assays reveal an allelic imbalance in p16(Ink4), GALT, p53, and APOA2 loci in patients with endometriosis. Fertil Steril. 2001;75:160–165
  19. Mhawech P, Kinkel K, Vlastos G, Pelte MF. Ovarian carcinomas in endometriosis: an immunohistochemical and comparative genomic hybridization study. Int J Gynecol Pathol. 2002;21(4):401–406
  20. Matalliotakis IM, Cakmak H, Mahutte N, Goumenou AG, Koumantakis G, Arici A. The familial risk of breast cancer in women with endometriosis from Yale series. Surg Oncol. 2008 Dec;17(4):289–293

PII: S0960-7404(09)00034-6

doi: 10.1016/j.suronc.2009.02.012

Surgical Oncology
Volume 19, Issue 1 , Pages 33-37 , March 2010

Article Tools